GPT Healthcare Ltd

GPT Healthcare Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with the latest insights into the company’s performance and outlook.

GPT Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a blend of bullish and bearish signals across key indicators. The stock’s recent upgrade from Hold to Buy by MarketsMOJO, accompanied by a Mojo Score of 72.0, highlights growing investor interest despite mixed technical trends.

GPT Healthcare Ltd has recently experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest an improving price momentum despite a slight dip in the stock price on 16 Jun 2026.

The 50-day moving average has crossed above the 200-day moving average for GPT Healthcare Ltd, signalling a golden cross on 15 Jun 2026. Yet, the stock declined 0.57% on the day this technical event occurred, and the monthly momentum indicators remain inconclusive. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context to assess the reliability of this crossover.

GPT Healthcare Ltd, a micro-cap player in the hospital sector, has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors as the stock navigates current market conditions.

GPT Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of indicator signals. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 30 September 2025, the stock’s technical parameters reveal a nuanced picture that investors should carefully analyse.

GPT Healthcare Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for this micro-cap hospital sector stock as it trades near ₹150.

GPT Healthcare Ltd, a micro-cap player in the hospital sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 30 September 2025, the stock’s technical indicators present a mixed picture, reflecting both resilience and caution in price action.

GPT Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd has demonstrated a notable shift in price momentum, transitioning from a mildly bearish to a mildly bullish technical trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a cautious but optimistic outlook for this micro-cap hospital sector stock.

GPT Healthcare Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a more compelling price proposition for investors. This change comes amid a mixed performance backdrop and evolving sector dynamics, prompting a reassessment of the stock’s relative appeal within the hospital industry.

GPT Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

GPT Healthcare Ltd has witnessed a significant improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a more compelling price proposition for investors, supported by favourable price-to-earnings and price-to-book value ratios relative to its historical averages and peer group. Despite a modest market cap and micro-cap status, the hospital sector stock is showing signs of renewed investor interest amid improving fundamentals and valuation metrics.

GPT Healthcare Ltd., a Kolkata-based hospital chain with a market capitalisation of ₹1,177.08 crores, reported its fourth quarter results for FY26 with net profit reaching ₹14.57 crores, marking a sequential increase of 55.50% quarter-on-quarter but representing a marginal 13.04% gain year-on-year. The stock reacted positively to the results, surging 3.87% to ₹143.45 on May 19, 2026, though it remains 22.38% below its 52-week high of ₹184.80.

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.